Do analysts recommend UTMD or OSUR?

OraSure Technologies has a consensus price target of $3.00, indicating a potential downside of 29.58%. Given OraSure Technologies' higher possible upside, analysts clearly believe OraSure Technologies is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

OraSure Technologies (OSUR) Competitors

$4.26 -0.04 (-0.93%)

Closing price 07/14/2026 04:00 PM Eastern

Extended Trading

$4.27 +0.01 (+0.23%)

As of 05:06 AM Eastern

Compare

OSUR vs. CERS, UTMD, ANIK, WST, and COO

Should you buy OraSure Technologies stock or one of its competitors? MarketBeat compares OraSure Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OraSure Technologies include Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), and Cooper Companies (COO). These companies are all part of the "health care supplies" industry.

How does OraSure Technologies compare to Cerus?

OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Cerus had 4 more articles in the media than OraSure Technologies. MarketBeat recorded 5 mentions for Cerus and 1 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 1.31 beat Cerus' score of 0.80 indicating that OraSure Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
OraSure Technologies	Positive
Cerus	Positive

OraSure Technologies has a beta of 1.01, indicating that its share price is 1% more volatile than the broader market. Comparatively, Cerus has a beta of 1.77, indicating that its share price is 77% more volatile than the broader market.

Cerus has a net margin of -4.41% compared to OraSure Technologies' net margin of -66.42%. Cerus' return on equity of -15.18% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-66.42%	-18.57%	-15.71%
Cerus	-4.41%	-15.18%	-4.38%

Cerus has higher revenue and earnings than OraSure Technologies. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.55	-$68.73M	-$1.04	N/A
Cerus	$206.13M	2.98	-$15.63M	-$0.05	N/A

93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 4.7% of OraSure Technologies shares are owned by company insiders. Comparatively, 5.3% of Cerus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

OraSure Technologies currently has a consensus target price of $3.00, indicating a potential downside of 29.58%. Cerus has a consensus target price of $4.00, indicating a potential upside of 30.29%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Cerus beats OraSure Technologies on 13 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to Utah Medical Products?

Utah Medical Products (NASDAQ:UTMD) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

In the previous week, Utah Medical Products and Utah Medical Products both had 1 articles in the media. OraSure Technologies' average media sentiment score of 1.31 beat Utah Medical Products' score of 0.93 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Utah Medical Products	Positive
OraSure Technologies	Positive

Utah Medical Products has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.01, indicating that its stock price is 1% more volatile than the broader market.

Utah Medical Products has higher earnings, but lower revenue than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.63	$11.29M	$3.38	20.19
OraSure Technologies	$115.02M	2.55	-$68.73M	-$1.04	N/A

Utah Medical Products has a net margin of 28.90% compared to OraSure Technologies' net margin of -66.42%. Utah Medical Products' return on equity of 9.13% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
OraSure Technologies	-66.42%	-18.57%	-15.71%

OraSure Technologies has a consensus price target of $3.00, indicating a potential downside of 29.58%. Given OraSure Technologies' higher possible upside, analysts clearly believe OraSure Technologies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by insiders. Comparatively, 4.7% of OraSure Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Utah Medical Products beats OraSure Technologies on 9 of the 14 factors compared between the two stocks.

How does OraSure Technologies compare to Anika Therapeutics?

OraSure Technologies (NASDAQ:OSUR) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Anika Therapeutics has a net margin of -9.52% compared to OraSure Technologies' net margin of -66.42%. Anika Therapeutics' return on equity of -5.90% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-66.42%	-18.57%	-15.71%
Anika Therapeutics	-9.52%	-5.90%	-4.52%

OraSure Technologies has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market. Comparatively, Anika Therapeutics has a beta of 0.23, meaning that its share price is 77% less volatile than the broader market.

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by insiders. Comparatively, 12.1% of Anika Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Anika Therapeutics had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for Anika Therapeutics and 1 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 1.31 beat Anika Therapeutics' score of 1.28 indicating that OraSure Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
OraSure Technologies	Positive
Anika Therapeutics	Positive

OraSure Technologies presently has a consensus target price of $3.00, indicating a potential downside of 29.58%. Anika Therapeutics has a consensus target price of $17.00, indicating a potential upside of 9.54%. Given Anika Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Anika Therapeutics is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Anika Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Anika Therapeutics has lower revenue, but higher earnings than OraSure Technologies. Anika Therapeutics is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.55	-$68.73M	-$1.04	N/A
Anika Therapeutics	$112.82M	1.83	-$10.88M	-$0.79	N/A

Summary

Anika Therapeutics beats OraSure Technologies on 10 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and OraSure Technologies (NASDAQ:OSUR) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

West Pharmaceutical Services has a net margin of 16.85% compared to OraSure Technologies' net margin of -66.42%. West Pharmaceutical Services' return on equity of 19.03% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
OraSure Technologies	-66.42%	-18.57%	-15.71%

West Pharmaceutical Services has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.01, indicating that its stock price is 1% more volatile than the broader market.

West Pharmaceutical Services has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	8.23	$493.70M	$7.48	47.88
OraSure Technologies	$115.02M	2.55	-$68.73M	-$1.04	N/A

West Pharmaceutical Services currently has a consensus price target of $363.17, indicating a potential upside of 1.39%. OraSure Technologies has a consensus price target of $3.00, indicating a potential downside of 29.58%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 4.7% of OraSure Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, West Pharmaceutical Services had 8 more articles in the media than OraSure Technologies. MarketBeat recorded 9 mentions for West Pharmaceutical Services and 1 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 1.31 beat West Pharmaceutical Services' score of 0.73 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
West Pharmaceutical Services	Positive
OraSure Technologies	Positive

Summary

West Pharmaceutical Services beats OraSure Technologies on 15 of the 17 factors compared between the two stocks.

How does OraSure Technologies compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and OraSure Technologies (NASDAQ:OSUR) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

Cooper Companies has a net margin of 5.57% compared to OraSure Technologies' net margin of -66.42%. Cooper Companies' return on equity of 10.88% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
OraSure Technologies	-66.42%	-18.57%	-15.71%

Cooper Companies has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.26	$374.90M	$1.18	58.06
OraSure Technologies	$115.02M	2.55	-$68.73M	-$1.04	N/A

Cooper Companies has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market.

In the previous week, Cooper Companies had 13 more articles in the media than OraSure Technologies. MarketBeat recorded 14 mentions for Cooper Companies and 1 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 1.31 beat Cooper Companies' score of 0.89 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Cooper Companies	Positive
OraSure Technologies	Positive

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 4.7% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cooper Companies currently has a consensus target price of $81.85, suggesting a potential upside of 19.47%. OraSure Technologies has a consensus target price of $3.00, suggesting a potential downside of 29.58%. Given Cooper Companies' stronger consensus rating and higher possible upside, analysts clearly believe Cooper Companies is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.38
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Cooper Companies beats OraSure Technologies on 13 of the 17 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OSUR vs. The Competition

Export

Metric	OraSure Technologies	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$296.05M	$8.67B	$6.86B	$12.44B
Dividend Yield	N/A	2.55%	2.68%	8.42%
P/E Ratio	-4.10	15.65	27.01	24.38
Price / Sales	2.55	6.52	521.33	91.92
Price / Cash	N/A	18.09	48.59	59.36
Price / Book	0.90	3.56	10.95	6.33
Net Income	-$68.73M	$228.19M	$3.59B	$331.02M
7 Day Performance	0.24%	-1.41%	-1.45%	-0.33%
1 Month Performance	2.16%	-2.08%	2.78%	-1.29%
1 Year Performance	36.98%	2.26%	28.53%	21.30%

OraSure Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OSUR OraSure Technologies	1.6404 of 5 stars	$4.26 -0.9%	$3.00 -29.6%	+38.8%	$296.05M	$115.02M	N/A	840	Positive News
CERS Cerus	3.2002 of 5 stars	$3.33 +1.5%	$4.00 +20.2%	+111.7%	$665.43M	$206.13M	N/A	290	News Coverage Short Interest Decrease
UTMD Utah Medical Products	1.5143 of 5 stars	$72.70 +1.2%	N/A	+20.4%	$228.36M	$38.52M	21.25	180
ANIK Anika Therapeutics	2.4124 of 5 stars	$16.03 +0.0%	$17.00 +6.0%	+34.6%	$216.38M	$112.82M	N/A	300	News Coverage
WST West Pharmaceutical Services	2.9966 of 5 stars	$356.28 -0.4%	$351.91 -1.2%	+59.4%	$25.37B	$3.07B	48.00	10,800	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OSUR) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OraSure Technologies (OSUR) Competitors

OSUR vs. CERS, UTMD, ANIK, WST, and COO

How does OraSure Technologies compare to Cerus?

Summary

How does OraSure Technologies compare to Utah Medical Products?

Summary

How does OraSure Technologies compare to Anika Therapeutics?

Summary

How does OraSure Technologies compare to West Pharmaceutical Services?

Summary

How does OraSure Technologies compare to Cooper Companies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OraSure Technologies (OSUR) Competitors

OSUR vs. CERS, UTMD, ANIK, WST, and COO

How does OraSure Technologies compare to Cerus?

Does the media prefer OSUR or CERS?

Which has more volatility and risk, OSUR or CERS?

Is OSUR or CERS more profitable?

Which has stronger earnings & valuation, OSUR or CERS?

Do institutionals and insiders believe in OSUR or CERS?

Do analysts recommend OSUR or CERS?

Summary

How does OraSure Technologies compare to Utah Medical Products?

Does the media prefer UTMD or OSUR?

Which has more volatility & risk, UTMD or OSUR?

Which has better valuation & earnings, UTMD or OSUR?

Is UTMD or OSUR more profitable?

Do analysts recommend UTMD or OSUR?

Do insiders and institutionals believe in UTMD or OSUR?

Summary

How does OraSure Technologies compare to Anika Therapeutics?

Is OSUR or ANIK more profitable?

Which has more risk and volatility, OSUR or ANIK?

Do institutionals & insiders have more ownership in OSUR or ANIK?

Does the media favor OSUR or ANIK?

Do analysts recommend OSUR or ANIK?

Which has stronger valuation and earnings, OSUR or ANIK?

Summary

How does OraSure Technologies compare to West Pharmaceutical Services?

Is WST or OSUR more profitable?

Which has more volatility & risk, WST or OSUR?

Which has stronger earnings and valuation, WST or OSUR?

Do analysts rate WST or OSUR?

Do institutionals and insiders believe in WST or OSUR?

Does the media favor WST or OSUR?

Summary

How does OraSure Technologies compare to Cooper Companies?

Is COO or OSUR more profitable?

Which has better earnings and valuation, COO or OSUR?

Which has more volatility & risk, COO or OSUR?

Does the media prefer COO or OSUR?

Do institutionals and insiders have more ownership in COO or OSUR?

Do analysts rate COO or OSUR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools